Reflections on: Pharmacokinetics of Intranasal Dexmedetomidine
- PMID: 37450919
- DOI: 10.1213/ANE.0000000000006581
Reflections on: Pharmacokinetics of Intranasal Dexmedetomidine
Comment on
-
Dose Escalation Pharmacokinetic Study of Intranasal Atomized Dexmedetomidine in Pediatric Patients With Congenital Heart Disease.Anesth Analg. 2023 Jan 1;136(1):152-162. doi: 10.1213/ANE.0000000000005988. Epub 2022 Apr 21. Anesth Analg. 2023. PMID: 35446797
References
-
- Grogan K, Thibault C, Moorthy G, Prodell J, Nicolson SC, Zuppa A. Dose escalation pharmacokinetic study of intranasal atomized dexmedetomidine in pediatric patients with congenital heart disease. Anesth Analg. 2023;136:152–162.
-
- Miller JW, Balyan R, Dong M, et al. Does intranasal dexmedetomidine provide adequate plasma concentrations for sedation in children: a pharmacokinetic study. Br J Anaesth. 2018;120:1056–1065.
-
- Wang CY, Ihmsen H, Hu ZY, et al. Pharmacokinetics of intranasally administered dexmedetomidine in Chinese children. Front Pharmacol. 2019;10:756.
-
- Li BL, Guan YP, Yuen VM, et al. Population pharmacokinetics of intranasal dexmedetomidine in infants and young children. Anesthesiology. 2022;137:163–175.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
